Like the other statins,<unk>  is indicated for hypercholesterolaemia (elevated cholesterol) and for the prevention of cardiovascular disease. A 2009 study of the 104-week LIVES trial found<unk>  increased HDL cholesterol, especially in patients with HDL lower than 40 mg/dL, who had a 24.6% rise, in addition to greatly reducing LDL cholesterol 31.3%. HDL improved in patients who switched from other statins and rose over time. In the 70-month CIRCLE observational study,<unk>  increased HDL more than atorvastatin. It has neutral or possibly beneficial effects on glucose control. As a consequence,<unk>  is likely to be appropriate for patients with metabolic syndrome plus high LDL, low HDL and diabetes mellitus.
Pitavastatin
Enoxaparin sodium
Ticlopidine
Palladin
Apixaban
Heparin
Dabigatran
Clopidogrel